LIMVAY Trademark

Trademark Overview

On Thursday, June 30, 2022, a trademark application was filed for LIMVAY with the United States Patent and Trademark Office. The USPTO has given the LIMVAY trademark a serial number of 97484283. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, January 27, 2025. This trademark is owned by Polaris Pharmaceuticals, Inc.. The LIMVAY trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of metabolic disorders
limvay

General Information

Serial Number97484283
Word MarkLIMVAY
Filing DateThursday, June 30, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, January 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 21, 2023

Trademark Statements

Goods and Servicespharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of metabolic disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePolaris Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NamePolaris Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, July 4, 2022NEW APPLICATION ENTERED
Wednesday, July 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 13, 2023ASSIGNED TO EXAMINER
Thursday, April 13, 2023NON-FINAL ACTION WRITTEN
Thursday, April 13, 2023NON-FINAL ACTION E-MAILED
Thursday, April 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 22, 2023FINAL REFUSAL WRITTEN
Saturday, April 22, 2023FINAL REFUSAL E-MAILED
Saturday, April 22, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, April 24, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, April 24, 2023EXAMINERS AMENDMENT E-MAILED
Monday, April 24, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, October 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 16, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 16, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 16, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 21, 2024WITHDRAWAL OF ATTORNEY GRANTED
Tuesday, June 18, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 18, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 18, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 18, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 18, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 18, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 21, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, June 18, 2024SOU EXTENSION 1 FILED
Monday, August 12, 2024SOU EXTENSION 1 GRANTED
Monday, August 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 12, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 13, 2024SOU EXTENSION 3 FILED
Wednesday, December 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 13, 2024SOU EXTENSION 2 GRANTED
Monday, January 27, 2025SOU EXTENSION 3 GRANTED
Monday, January 27, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 13, 2024SOU TEAS EXTENSION RECEIVED
Friday, December 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 13, 2024SOU EXTENSION 2 FILED

Related Keywords

limvay pharmaceutical treatment products disorders cancer metabolic